This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Unlocking the mysteries of VLDL: exploring its production, intracellular trafficking, and metabolism as therapeutic targets
Lipids in Health and Disease Open Access 12 January 2024
-
A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B
Communications Biology Open Access 24 April 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
09 July 2010
In the version of this article initially published, some of the oligos in Table 1 are described as phosphorothioate modified. In fact, all antisense oligonucleotides are phosphorothioate-modified oligos. In addition, Lucanix, which is not an antisense oligo, has been removed from the table.The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kling, J. Safety signal dampens reception for mipomersen antisense. Nat Biotechnol 28, 295–296 (2010). https://doi.org/10.1038/nbt0410-295
Issue Date:
DOI: https://doi.org/10.1038/nbt0410-295
This article is cited by
-
Unlocking the mysteries of VLDL: exploring its production, intracellular trafficking, and metabolism as therapeutic targets
Lipids in Health and Disease (2024)
-
A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B
Communications Biology (2023)
-
Antisense battles small molecule for slice of rare lipid disorder market
Nature Biotechnology (2013)
-
Biologics inch toward cholesterol-lowering market
Nature Biotechnology (2012)
-
Compensatory and non-compensatory effects on protein expression following BCL-2 suppression by antisense oligonucleotides
Medical Oncology (2012)